Healthcare Services

Pediatric Clinical Trials Market Future Outlook Showing Expansion Toward $26.66 Billion by 2030

April 3, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Expected Market Size Of The Pediatric Clinical Trials Market From 2026 To 2030?

The pediatric clinical trials market size has experienced strong growth in recent years. It is projected to increase from $18.38 billion in 2025 to $19.75 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.4%. The expansion during the historic period can be linked to factors such as limited pediatric-specific drug research, reliance on adult trial data, ethical and regulatory challenges, low patient recruitment rates, and minimal use of advanced analytics in trial design.

The pediatric clinical trials market is projected to experience substantial expansion in the coming years. It is forecast to reach $26.67 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.8%. This growth during the forecast period is fueled by several factors, including the increasing demand for therapies tailored to children, the wider use of digital and AI technologies, enhanced regulatory encouragement for pediatric research, strengthened partnerships between pharmaceutical companies and research institutions, and a greater emphasis on clinical trials that are patient-centric and individualized. Key trends anticipated for this period involve the expanding integration of precision medicine within pediatric clinical trials, the growing application of AI and digital tools for designing trials and analyzing data, the greater incorporation of real-world evidence into pediatric research, increased capital expenditure in the development of pediatric drugs, and a heightened emphasis on therapeutic approaches that are personalized and age-specific.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10350&type=smp

What Key Drivers Are Influencing The Growth Of The Pediatric Clinical Trials Market?

The increasing incidence of pediatric cancer cases is projected to fuel the pediatric clinical trials market in the future. Pediatric cancer is defined as malignancies that develop in children and adolescents under the age of 14. These cancers are considerably uncommon, and their growth and dissemination patterns can differ from those observed in adult tumors. Pediatric clinical trials continue to be instrumental in improving prognosis and treatment. For example, in January 2023, the American Cancer Society, a US-based voluntary health organization, estimated that approximately 9,910 children in the US under the age of 15 would be diagnosed with cancer, and about 1,040 children under 15 were expected to die from cancer in 2023. Consequently, increasing healthcare expenditure is also propelling the pediatric clinical trials market.

Which Segments Are Included In The Analysis Of The Pediatric Clinical Trials Market?

The pediatric clinical trials market covered in this report is segmented –

1) By Phase: Phase I, Phase II, Phase III, Phase IV

2) By Study Design: Treatment Studies, Observational Studies

3) By Therapeutic Areas: Infectious Diseases, Oncology, Autoimmune Or Inflammatory Diseases, Respiratory Disorders, Mental Health Disorders, Other Therapeutic Areas

Subsegments:

1) By Phase I: First-in-Pediatrics Trials, Dose Escalation Studies, Safety And Tolerability Assessments

2) By Phase II: Efficacy Studies, Dose Optimization Trials, Pharmacokinetic Studies

3) By Phase III: Large-Scale Efficacy Trials, Comparative Studies, Long-Term Safety Studies

4) By Phase IV: Post-Marketing Surveillance, Long-Term Safety Monitoring, Effectiveness Studies In Real-World Settings

Which Upcoming Trends Are Expected To Influence The Pediatric Clinical Trials Market?

Companies at the forefront of pediatric clinical trials are emphasizing cooperation and partnerships to offer reliable services to their clients. A strategic partnership represents a structured relationship between two or more commercial entities, typically established through one or more business agreements or contracts. For instance, in September 2023, Strados Labs, a US-based provider of smart biosensors for respiratory monitoring, joined forces with Ann & Robert H. Lurie Children’s Hospital, a US-based pediatric acute care children’s hospital, to conduct a clinical trial for the RESP Biosensor. This RESP Biosensor is a wearable device that employs acoustic sensors to monitor lung sounds for asthma symptoms like coughing and wheezing. The clinical trial’s main goal is to evaluate how effective the RESP Biosensor is at accurately detecting and monitoring asthma exacerbations in children.

Which Key Industry Participants Are Active In The Pediatric Clinical Trials Market?

Major companies operating in the pediatric clinical trials market are Medpac Inc., Pharmaceutical Product Development Inc., ICON plc, Syneos Health Inc., QPS Holdings LLC, Pfizer Inc., IQVIA Inc., Premier Research, Labcorp – Laboratory Corporation of America Holdings, The Emmes Company LLC, Synteract Inc., Charles River Laboratories International Inc., Covance Inc., Bristol-Myers Squibb Company, GlaxoSmithKline plc, BioNTech SE, Moderna Inc., Parexel International Corporation, PRA Health Sciences, Wuxi AppTec, Merck & Co. Inc., AstraZeneca plc, Sanofi S.A., Johnson & Johnson, Eli Lilly and Company, Takeda Pharmaceutical Company Limited, C.H. Boehringer Sohn AG & Co. KG, AbbVie Inc., Teva Pharmaceutical Industries Ltd., Oracle Health sciences

Read the full pediatric clinical trials market report here:

https://www.thebusinessresearchcompany.com/report/pediatric-clinical-trials-global-market-report

Which Region Is Expected To Register The Fastest Growth In The Pediatric Clinical Trials Market?

North America was the largest region in the pediatric clinical trials market in 2025. The regions covered in the pediatric clinical trials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Pediatric Clinical Trials Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=10350&type=smp

Browse Through More Reports Similar to the Global Pediatric Clinical Trials Market 2026, By The Business Research Company

Brain Tumor Drugs Global Market Report

https://www.thebusinessresearchcompany.com/report/brain-tumor-drugs-global-market-report

Pediatric Imaging Global Market Report

https://www.thebusinessresearchcompany.com/report/pediatric-imaging-global-market-report

Paraganglioma Global Market Report

https://www.thebusinessresearchcompany.com/report/paraganglioma-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795